- Home
- YAAS vs MNOV Comparison
YAAS vs MNOV Comparison
Compare YAAS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YAAS
- MNOV
- Stock Information
- Founded
- YAAS 2018
- MNOV 2000
- Country
- YAAS China
- MNOV United States
- Employees
- YAAS N/A
- MNOV N/A
- Industry
- YAAS Computer Software: Prepackaged Software
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- YAAS Technology
- MNOV Health Care
- Exchange
- YAAS Nasdaq
- MNOV Nasdaq
- Market Cap
- YAAS 59.0M
- MNOV 68.2M
- IPO Year
- YAAS 2024
- MNOV 2005
- Fundamental
- Price
- YAAS $3.03
- MNOV $1.30
- Analyst Decision
- YAAS
- MNOV Strong Buy
- Analyst Count
- YAAS 0
- MNOV 2
- Target Price
- YAAS N/A
- MNOV $7.00
- AVG Volume (30 Days)
- YAAS 44.0K
- MNOV 10.2K
- Earning Date
- YAAS 08-15-2025
- MNOV 08-07-2025
- Dividend Yield
- YAAS N/A
- MNOV N/A
- EPS Growth
- YAAS N/A
- MNOV N/A
- EPS
- YAAS N/A
- MNOV N/A
- Revenue
- YAAS $521,240.00
- MNOV N/A
- Revenue This Year
- YAAS N/A
- MNOV N/A
- Revenue Next Year
- YAAS N/A
- MNOV N/A
- P/E Ratio
- YAAS N/A
- MNOV N/A
- Revenue Growth
- YAAS N/A
- MNOV N/A
- 52 Week Low
- YAAS $1.58
- MNOV $1.12
- 52 Week High
- YAAS $4.25
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- YAAS N/A
- MNOV 32.85
- Support Level
- YAAS N/A
- MNOV $1.25
- Resistance Level
- YAAS N/A
- MNOV $1.34
- Average True Range (ATR)
- YAAS 0.00
- MNOV 0.04
- MACD
- YAAS 0.00
- MNOV -0.01
- Stochastic Oscillator
- YAAS 0.00
- MNOV 4.55
About YAAS Youxin Technology Ltd Class A Ordinary shares
Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.